Clonidine Toxicity Revisited

REFERENCES

• Kappagoda C., Schell D.N., Hanson R.M., Hutchins P. Clonidine Overdose in Childhood: Implications of Increased Prescribing. J. Paediatr. Child Health 1998; 34(6)508–512
   PubMed Web of Science ®Google Scholar
• Olsson J.M., Pruitt A.W. Management of Clonidine Ingestion in Children. J. Pediatr. 1983; 103(4)646–650
   PubMed Web of Science ®Google Scholar
• Knapp J.F., Fowler M.A., Wheeler C.A., Wasserman G.S. Case 01-1995: A Two-Year-Old Female with Alteration of Consciousness. Pediatr. Emerg. Care 1995; 11(1)62–65
   PubMed Web of Science ®Google Scholar
• Fiser D.H., Moss M.M., Walker W. Critical Care for Clonidine Poisoning in Toddlers. Crit. Care Med. 1990; 18(10)1124–1128
   PubMed Web of Science ®Google Scholar
• Heidemann S.M., Sarnaik A.P. Clonidine Poisoning in Children. Crit. Care Med. 1990; 18(6)618–620
   PubMed Web of Science ®Google Scholar
• Oats J.A. Antihypertensive Agents and the Drug Therapy of Hypertension. Goodman and Gilman's The Pharmacological Basis of Therapeutics, J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Gilman. 9th Ed., McGraw-Hill, New York 1996; 780–808
   Google Scholar
• Nishina K., Miawa K., Shiga M., Obara H. Clonidine in Paediatric Anaesthesia. Paediatr. Anaesth. 1999; 9(3)187–202
   PubMedGoogle Scholar
• Head G.A., Gundlach A.L., Musgrave I.F. Recent Advances in Imidazoline Receptor Research; Ligands-Localization and Isolation-Signaling-Functional and Clinical Studies. J. Auton. Nerv. Syst. 1998; 72(2–3)74–79
   PubMedGoogle Scholar
• Hamilton C.A. The Role of Imidazoline Receptors in Blood Pressure Regulation. Pharmacol. Ther. 1992; 54(3)231–248
   PubMed Web of Science ®Google Scholar
• Talke P.O., Caldwell J.E., Richardson C.A., Heier T. The Effects of Clonidine on Human Digital Vasculature. Anesth. Analg. 2000; 91(4)793–797
   PubMed Web of Science ®Google Scholar
• Saunders C., Limbird L.E. Localization and Trafficking of α2-Adrenergic Receptor Subtypes in Cells and Tissues. Pharmacol. Ther. 1999; 84(2)193–205
   PubMed Web of Science ®Google Scholar
• Docherty J.R. Subtypes of Functional α1- and α2-Adrenoceptors. Eur. J. Pharmacol. 1998; 361(1)1–15
   PubMed Web of Science ®Google Scholar
• Khan Z.P., Ferguson C.N., Jones R.M. Alpha-2 and Imidazoline Receptor Agonists. Anaesthesia 1999; 54(2)146–165
   PubMed Web of Science ®Google Scholar
• Dominiak P. Historic Aspects in the Identification of the I1 Receptor and the Pharmacology of Imidazolines. Cardiovasc. Drugs Ther. 1994; 8(Suppl. 1)21–26
   PubMedGoogle Scholar
• Bousquet P., Feldaman J., Atlas D. An Endogenous, Non-catecholamine Clonidine Antagonist Increases Mean Arterial Blood Pressure. Eur. J. Pharmacol. 1986; 124(1–2)167–170
   PubMed Web of Science ®Google Scholar
• Meeley M.P., Ernsberger P.R., Granata A.R., Reis D.J. An Endogenous Clonidine-Displacing Substance from Bovine Brain: Receptor Binding and Hypotensive Actions in the Ventrolateral Medula. Life Sci. 1986; 38(12)1119–1126
   PubMed Web of Science ®Google Scholar
• Molderings G.J. Imidazoline Receptors: Basic Knowledge, Recent Advances and Future Prospects for Therapy and Diagnosis. Drugs Future 1997; 22: 757–772
   Google Scholar
• Meana J.J., Herrera-Marschitz M., Goiny M., Silveira R. Modulation of Catecholamine Release by α2-Adrenoceptors and I1-Imidazoline Receptors in Rat Brain. Brain Res. 1997; 744(2)216–226
   PubMed Web of Science ®Google Scholar
• Head G.A., Chan C.K.S., Burke S.L. Relationship Between Imidazoline and α2-Adrenoceptors Involved in the Sympatho-Inhibitory Actions of Centrally Acting Antihypertensive Agents. J. Auton. Nerv. Syst. 1998; 72(2–3)163–169
   PubMedGoogle Scholar
• Bousquet P., Brauban V., Schann S., Greney H., Ehrhardt J.D., Dontenwill M., Feldman J. Participation of Imidazoline Receptor and Alpha2-Adrenoceptors in the Central Hypotensive Effects of Imidazoline-Like Drugs. Ann. NY Acad. Sci. 1999; 881: 272–278
   PubMed Web of Science ®Google Scholar
• Berridge C.W., Abercrombie E.D. Relationship Between Locus Coeruleus Discharge Rates and Rates of Norepinephrine Release Within Neocortex as Needed by In Vivo Microdialysis. Neuroscience 1999; 93(4)1263–1270
   PubMed Web of Science ®Google Scholar
• Timmermans P., Schoop A.M., Kwa H.Y., Van Zwieten P.A. Characterization of α-Adrenoceptors Participating in the Central Hypotensive and Sedative Effects of Clonidine Using Yohimbine, Rauwolscine and Corynanthine. Eur. J. Pharmacol. 1981; 70(1)7–15
   PubMed Web of Science ®Google Scholar
• , Newcorn, J.H.; Schulz, K.; Harrison, M.; DeBellis, M.D.; Udarbe, J.K.; Halperin, J.M. α2 Adrenergic Agonisits: Neurochemistry, Efficacy, and Clinical Guidelines for Use in Children. In Child and Adolescent Psychopharmacology, Findling, R.L.; Blumer, J.L., Eds.; Pediatric Clinics of North America; W. B. Saunders: Philadelphia, 1998; Vol. 45(5), 1099–1122.
   Google Scholar
• Tibirica E., Feldman J., Mermet C., Gonon F., Bousquet P. An Imidazoline-Specific Mechanism for the Hypotensive Effect of Clonidine; A Study with Yohimbine and Idazoxan. J. Pharmacol. Exp. Ther. 1991; 256(2)606–613
   PubMed Web of Science ®Google Scholar
• Ricci D., Taira C.A. Importance of Imidazoline Receptors in the Cardiovascular Responses of Clonidine in Sinoaortic Denervated Rats. Ann. NY Acad. Sci. 1999; 881: 290–294
   PubMed Web of Science ®Google Scholar
• Head G.A. Central Imidazoline and [Alpha]2-Receptors Involved in the Cardiovascular Actions of Centrally Acting Antihypertensive Agentsa. Ann. NY Acad. Sci. 1999; 881: 279–286
   PubMed Web of Science ®Google Scholar
• Fraser J., Macrae D. Inhaled Nitric Oxide and the Critically Ill Child. Clin. Intensive Care 2001; 12(1)11–20
   Google Scholar
• Venturini G., Colasanti M., Persichini T., Fioravanti E., Federico R., Ascenzi P. Selective Inhibition of Nitric Oxide Synthase Type I by Clonidine, and Anti-Hypertensive Drug. Biochem. Pharmacol. 2000; 60(4)539–544
   PubMed Web of Science ®Google Scholar
• Soares de Moura R., Leão M.C., Resende C., Moreira C.F., Sena K.M.S., Silveira S.S., Lima A.F., Nunes F.R., Mesquita Ferreira A.G. Actions of l-NAME and Methylene Blue on the Hypotensive Effects of Clonidine and Rilmenidine in the Anesthetized Rat. J. Cardiovasc. Pharmacol. 2000; 35(5)791–795
   PubMed Web of Science ®Google Scholar
• Artman M., Boerth R. Clonidine Poisoning. A Complex Problem. Am. J. Dis. Child. 1983; 137(2)171–174
   PubMedGoogle Scholar
• Egleme C., Godfraind T., Miller R.C. Enhanced Responsiveness of Rat Isolated Aorta to Clonidine After Removal of the Endothelial Cells. Br. J. Pharmacol. 1984; 81(1)16–18
   PubMed Web of Science ®Google Scholar
• Mombouli J.V., Vanhoutte P.M. Endothelial Dysfunction: From Physiology to Therapy. J. Mol. Cell. Cardiol. 1999; 31(1)61–74
   PubMed Web of Science ®Google Scholar
• Murai T., Yoshida Y., Koide S., Takada K., Misaki T., Koshikawa N., Cools A.R. Clonidine Reduces Dopamine and Increases GABA in the Nucleus Accumbens: An In Vivo Microdialysis Study. Pharmacol. Biochem. Behav. 1998; 60(3)695–701
   PubMed Web of Science ®Google Scholar
• Czyzewska-Szafran H., Wutkiewicz M., Remiszewska M., Jastrzebski Z., Czarnecki A., Danysz A. Down-Regualtion of the GABAergic System in Selected Brain Areas of Spontaneously Hypertensive Rats (SHR). Pol. J. Pharmacol. 1989; 41: 619–627
   Google Scholar
• Sun M.K., Reis D.J. GABA-Mediated Inhibition of Pace Maker Neurons of Rostral Ventrolateral Medulla by Clonidine In Vitro. Eur. J. Pharmacol. 1995; 276(3)291–296
   PubMed Web of Science ®Google Scholar
• Castro J.L., Ricci D., Taira C.A., Ramirez A. Central Benzodiazepine Involvement in Clonidine Cardiovascular Actions. Can. J. Physiol. Pharmacol. 1995; 77(11)844–851
   Google Scholar
• Gozliniska B., Czyzewska-Szafran H. Clonidine Action in Spontaneously Hypertensive Rats (SHR) Depends on the GABAergic System Function. Amino Acids 1999; 17(2)131–138
   PubMed Web of Science ®Google Scholar
• Sasaki S., Nakata T., Kawasaki S., Hayashi J., Oguro M., Takeda K.K. Chronic Central GABAergic Stimulation Attenuates Hypothalamic Hyperactivity and Development of Spontaneous Hypertension in Rats. J. Cardiovasc. Pharmacol. 1990; 15(5)706–713
   PubMed Web of Science ®Google Scholar
• North O.S., Wieland M.J., Peterson C.D., Krenzelok E.P. Nalxone Administration in Clonidine Overdosage. Ann. Emerg. Med. 1981; 10(7)397
   PubMed Web of Science ®Google Scholar
• Kulig K.M., Duffy J., Rumack B.H. Naloxone for Treatment of Clonidine Overdose. J. Am. Med. Assoc. 1982; 247(12)1697
   Web of Science ®Google Scholar
• Banner W., Jr, Lund M.E., Clawson L. Failure of Naloxone to Reverse Clonidine Toxic Effect. Am. J. Dis. Child. 1983; 137(12)1170–1171
   PubMedGoogle Scholar
• Bamshad M.J., Wasserman G.S. Pediatric Clonidine Intoxications. Vet. Hum. Toxicol. 1990; 32(3)220–223
   PubMedGoogle Scholar
• Fiser D.A., Moss M.M., Walker W. Critical Care for Clonidine Poisoning in Toddlers. Crit. Care Med. 1990; 18(10)1124–1128
   PubMed Web of Science ®Google Scholar
• Kappagoda C., Schell D.N., Hanson R.M., Hutchins P. Clonidine Overdose in Childhood: Implications of Increased Prescribing. J. Paediatr. Child Health 1998; 34(6)508–512
   PubMed Web of Science ®Google Scholar
• Heidemann S.M., Sarnaik A.P. Clonidine Poisoning in Children. Crit. Care Med. 1990; 18(6)618–620
   PubMed Web of Science ®Google Scholar
• Yagupsky P., Gorodischer R. Massive Clonidine Ingestion with Hypertension in a 9-Month-Old Infant. Pediatrics 1983; 72(4)500–502
   PubMed Web of Science ®Google Scholar
• Schieber R.A., Kaufman N.D. Use of Tolazoline in Massive Clonidine Poisoning. Am. J. Dis. Child. 1981; 135(1)77–78
   PubMedGoogle Scholar
• Marruecos M.D., Rogland A., Frati M.E., Artigas A. Clonidine Overdose. Crit. Care Med. 1983; 11(12)959–960
   PubMed Web of Science ®Google Scholar
• Hunyor S.N., Bradstock K., Somerville P.J., Lucas N. Clonidine Overdose. Br. Med. J. 1975; 23
   PubMed Web of Science ®Google Scholar
• Davies D.S., Wing M.H., Reid J.L., Neill E., Tippett P., Dollery C.T. Pharmacokinetics and Concentration–Effect Relationships of Intravenous and Oral Clonidine. Clin. Pharmacol. Ther. 1976; 21(5)593–601
   Web of Science ®Google Scholar
• Dollery C.T., Davies D.S., Draffan G.H., Dargie H.J., Dean C.R., Reid J.L., Clare R.A., Murray S. Clinical Pharmacology and Pharmacokinetics of Clonidine. Clin. Pharmacol. Ther. 1975; 19(1)11–17
   Web of Science ®Google Scholar
• Williams P.L., Krafcik J.M., Potter B.B., Hooper J.H., Hearne M.J. Cardiac Toxicity of Clonidine. Chest 1977; 72(6)784–785
   PubMed Web of Science ®Google Scholar
• Kibler L.E., Gazes P.C. Effect of Clonidine on Atrioventricular Conduction. J. Am. Med Assoc. 1977; 238(18)1930–1932
   Web of Science ®Google Scholar
• Dawson P.M., Zander J.A., Werkman S.L., Washington R.L., Tyma T.A. Cardiac Dysrthythmia with the Use of Clonidine in Explosive Disorder. DICP Ann. Pharmacother. 1989; 23(6)465–466
   PubMedGoogle Scholar
• Chandran K.S.K. ECG and Clonidine. J. Am. Acad. Child Adolesc. Psychiatry [Letter] 1994; 33(9)1351–1352
   PubMed Web of Science ®Google Scholar
• Fontana F., Bernardi P., Spampinato A., Boschi S., De Iasio R., Grossi G. Pressor Effects of Endogenous Opioid System During Acute Episodes of Blood Pressure Increases in Hypertensive Patients. Hypertension 1997; 29(1 Pt 1)105–110
   PubMed Web of Science ®Google Scholar
• Caffrey J., Wooldridge C.B., Gaul J.F. Naloxone Enhances Myocardial Responses to Isoproterenol in Dog Isolated Heart–Lung. Am. J. Physiol. 1986; 250(5 Pt 2)H749–H754
   PubMed Web of Science ®Google Scholar
• Curtis M.T., Lefer A.M. Protective Actions of Naloxone in Hemorrhagic Shock. Am. J. Physiol. 1980; 239(3)H416–H421
   PubMed Web of Science ®Google Scholar
• Hughes J., Kosterlitz H.W., Smith T.W. The Distribution Methionine-Enkephalin and Leucine-Enkephalin in the Brain and Peripheral Tissues. Br. J. Pharmacol. 1977; 61(4)639–647
   PubMed Web of Science ®Google Scholar
• Viveros O.H., Diliberto E.J., Hazum E., Chang K.J. Opiate-Like Materials in the Adenal Medulla: Evidence for Storage and Secretion with Catecholamines. Mol. Pharmacol. 1979; 16(3)1101–1108
   PubMed Web of Science ®Google Scholar
• Stock G., Schmelz M., Knuepfer M.M., Forssmann W.G. Functional and Anatomic Aspects of Central Nervous Cardiovascular Regulation. Central Cardiovascular Control, D. Ganten, D. Pfaff. Springer, New York 1983; 1–24
   Google Scholar
• Gaddis R.R., Dixon W.R. Modulation of Peripheral Adrenergic Neurotransmission by Methionine-Enkephalin. J. Pharmacol. Exp. Ther. 1982; 221(2)282–287
   PubMed Web of Science ®Google Scholar
• Mroczek W.J., Davidov M., Finnerty F.A. Intravenous Clonidine in Hypertensive Patients. Clin. Pharmacol. Ther. 1973; 14(5)847–851
   PubMed Web of Science ®Google Scholar
• Mannelli M., Maggi M., DeFeo M.L., Cuomo S., Forti G., Moroni F., Giusti G. Naloxone Administration Releases Catecholamines. N. Engl. J. Med. 1983; 308(11)654–655
   PubMed Web of Science ®Google Scholar
• Kolaric S., Makulska-Nowak H.E., Gumulka S.W., Mizerska K. Paradoxical Effects of Intracerebroventricular Low-Dose Opioid Antagonists in SHR with Chronic Pain. Life Sci. 1999; 65(4)395–402
   PubMed Web of Science ®Google Scholar
• Jin C.M., Rockhold R.W. Sympathoadrenal Control by Paraventricular Hypothalamic β-Endorphin in Hypertension. Hypertension 1991; 18(4)503–515
   PubMed Web of Science ®Google Scholar
• Farsang C., Ramirez-Gonzalez M.D.R., Mucci L., Kunos G. Possible Role of an Endogenous Opiate in the Cardiovascular Effects of Central Alpha Adrenoceptor Stimulation in Spontaneously Hypertensive Rats. J. Pharmacol. Exp. Ther. 1980; 214(1)203–208
   PubMed Web of Science ®Google Scholar
• Farsang C., Kapocsi J., Vajda L., Varga K., Malisak Z., Fekete M., Kunos G. Reversal by Naloxone of the Antihypertensive Action of Clonidine; Involvement of the Sympathetic Nervous System. Hypertension 1984; 69(3)461–467
   Google Scholar
• Tenenbein M. Naloxone in Clonidine Toxicity. Am. J. Dis. Child. 1984; 138(11)1084–1085
   PubMedGoogle Scholar
• Nichols M.H., King W.D., James L.P. Clonidine Poisoning in Jefferson County, Alabama. Ann. Emerg. Med. 1997; 29(4)511–517
   PubMed Web of Science ®Google Scholar
• Wiley J.F., Wiley C.C., Torrey S.B., Henretig F.M. Clonidine Poisoning in Young Children. J. Pediatr. 1990; 116(4)654–658
   PubMed Web of Science ®Google Scholar
• Maggi J.C., Iskra M.K., Nussbaum E. Severe Clonidine Overdose in Children Requiring Critical Care. Clin. Pediatr. (Phila.) 1986; 25(9)453–455
   PubMed Web of Science ®Google Scholar
• Cook P. Clonidine-Induced Unconsciousness: Reversal with Naloxone. Anaesth. Intensive Care 1987; 15(4)470–471
   PubMed Web of Science ®Google Scholar
• Gremse D.A., Artman M., Boerth R.C. Hypertension Associated with Naloxone Treatment for Clonidine Poisoning. J. Pediatr. 1986; 108(5 Pt 1)776–778
   PubMed Web of Science ®Google Scholar
• Ziegler M.G., Lake C.R., Kopin I.J. Plasma Noradrenaline Increases with Age. Nature 1976; 261(5558)333–335
   PubMed Web of Science ®Google Scholar
• Yoshioka S., Mitani H., Maeda K., Takeo S., Matsuda K., Katayama S., Mizukawa R., Kawahara R. Age-Specific Effects of Noradrenergic Alpha-2 Agonist Clonidine on the Development of Amygdaloid Kindling in Developing Rats. Dev. Brain Res. 2000; 119(2)283–288
   PubMedGoogle Scholar
• Callado L.F., Meana J.J., Grijalba B., Pazos A., Sastre M., Garcia-Sevilla J. Selective Increase of α2A-Adrenoceptor Agonist Binding Sites in Brains of Depressed Suicide Victims. J. Neurochem. 1998; 70(3)1114–1123
   PubMed Web of Science ®Google Scholar